Fate Therapeutics Inc. (FATE) Business Metrics | Revenue Breakdown & Segment Analysis - Stocknear

Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
0.97
-0.04 (-3.96%)
At close: Sep 08, 2025, 3:59 PM

Upfront Fee And Equity Premium Revenue

History

Quarter Value Change Growth
Dec 31, 2023 0 -31.2M -100.00%
Sep 30, 2023 31.2M n/a n/a
Jun 30, 2023 31.2M n/a n/a
Mar 31, 2023 31.2M 25.2M +420.00%
Dec 31, 2022 6M 1.8M +42.86%
Sep 30, 2022 4.2M -2.5M -37.31%
Jun 30, 2022 6.7M 600K +9.84%
Mar 31, 2022 6.1M 2M +48.78%
Sep 30, 2021 4.1M 300K +7.89%
Jun 30, 2021 3.8M 2M +111.11%
Mar 31, 2021 1.8M n/a n/a